Trials / Completed
CompletedNCT04210297
Development and Validation of an Noninvasive Model for Predicting High Risk Esophageal Varices in Cirrhosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 245 (actual)
- Sponsor
- Qilu Hospital of Shandong University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to develop and validate a new noninvasive method based on routine examination during clinical practice for predicting high risk esophageal varices in cirrhosis.
Detailed description
Portal hypertension is the main consequence of cirrhosis. Variceal bleeding is the principal and life-threatening complication of portal hypertension. Endoscopic screening is the golden standard to detect esophageal varices. However, endoscopy is limited by its invasiveness, cost and the discomfort it imposes on patients. With the goal of circumventing these disadvantages, we intend to develop an noninvasive method for predicting high risk esophageal varices.
Conditions
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2019-10-01
- Completion
- 2021-01-01
- First posted
- 2019-12-24
- Last updated
- 2021-05-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04210297. Inclusion in this directory is not an endorsement.